Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.63 CAD | -0.91% | -2.43% | +4.81% |
Mar. 11 | Extendicare Price Target Raised to $8 at RBC | MT |
Mar. 08 | Transcript : Extendicare Inc., Q4 2023 Earnings Call, Mar 08, 2024 |
Sales 2024 * | 1.35B 994M | Sales 2025 * | 1.37B 1.01B | Capitalization | 640M 473M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.48 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.47 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 23,500 |
Yield 2024 * |
6.23% | Yield 2025 * |
10.6% | Free-Float | 86.35% |
Latest transcript on Extendicare Inc.
1 day | -0.52% | ||
1 week | -2.05% | ||
Current month | +13.31% | ||
1 month | +10.69% | ||
3 months | +5.51% | ||
6 months | +26.40% | ||
Current year | +5.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-03-11 | |
David Bacon
DFI | Director of Finance/CFO | - | 19-03-31 |
Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Aladin Mawani
BRD | Director/Board Member | 72 | 17-11-30 |
Alvin G. Libin
BRD | Director/Board Member | - | 84-01-19 |
Chief Executive Officer | 60 | 18-03-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 11 M€ | -.--% | ||
0.04% | 1 M€ | -.--% | - | |
0.00% | 735 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 7.63 | -0.91% | 93 550 |
24-03-27 | 7.7 | +0.65% | 88,249 |
24-03-26 | 7.65 | +0.66% | 85,551 |
24-03-25 | 7.6 | -0.65% | 109,137 |
24-03-22 | 7.65 | -2.17% | 81,801 |
Delayed Quote Toronto S.E., March 28, 2024 at 11:39 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.22% | 471M | |
+0.96% | 99.96B | |
+22.54% | 87.73B | |
+10.63% | 29.33B | |
-4.45% | 18.21B | |
-3.83% | 14.51B | |
+19.55% | 12.22B | |
+31.32% | 12B | |
+0.03% | 11.94B | |
-11.47% | 11.63B |